Market Trends
8 min read · March 2026
Gummy Supplement Trends 2025: What's Driving Growth and What's Next
The gummy supplement market is evolving fast. New ingredients, new formats, and shifting consumer expectations are reshaping what brands need to offer — and what CDMOs need to be capable of manufacturing.
Excelsia Labs Team
Gummy Manufacturing Experts · Greece
1. The Gummy Format Is Now the Default, Not the Exception
Five years ago, gummies were still considered a niche format — mainly associated with children's vitamins and a handful of adult sleep and beauty supplements. That perception has fundamentally shifted. In 2025, the gummy format is the first choice for a growing majority of supplement consumers across all age groups.
Ease of consumption, palatability, and the elimination of pill fatigue are the primary drivers. Brands that previously offered tablets or capsules as their core SKU are now launching gummy equivalents — and in many cases, the gummy version is outselling the original format within the first year.
2. High-Actives Formulations Are the New Frontier
The early wave of gummy supplements focused on low-dose vitamins and minerals — ingredients that are easy to incorporate into a gummy matrix without compromising texture, stability, or taste. The current wave is far more technically demanding.
Creatine
Creatine monohydrate gummies are one of the fastest-growing segments in sports nutrition. Delivering 3–5g per serving in a gummy format requires sophisticated formulation — managing heat degradation, pH sensitivity, and water activity throughout the manufacturing process.
Collagen
Collagen peptides at meaningful doses (2.5–5g) present their own formulation challenges — particularly around texture, as collagen has a significant impact on gummy firmness and chew. Getting the right balance of efficacy and consumer experience requires R&D investment that not every CDMO is equipped for.
Magnesium
Magnesium in various forms — glycinate, citrate, malate — is seeing surging demand driven by consumer awareness of its role in sleep, stress, and muscle function. Gummy delivery is increasingly preferred, though the high mineral load requires careful management of taste masking and texture.
3. Sleep and Stress Support Continues to Dominate
Sleep gummies remain one of the highest-volume categories in the global supplement market, and demand shows no signs of plateauing. Melatonin remains the anchor ingredient, but formulators and brands are increasingly layering in adaptogens — ashwagandha, L-theanine, passionflower, and lemon balm — to create more differentiated products.
The regulatory environment around melatonin is also evolving in key markets. In the EU, melatonin gummies are classified as borderline products, with dose restrictions that vary by country. Brands entering European markets need a manufacturing partner with regulatory fluency — not just production capacity.
Stress support is an adjacent growth category, with products combining adaptogens like rhodiola and ashwagandha with B vitamins and magnesium. Consumer demand here is being driven by broader awareness of the cortisol-sleep-performance connection — particularly among younger, health-conscious demographics.
For CDMOs, this creates demand for formulation expertise with botanical extracts — an area where standardisation, stability, and QC requirements are significantly more complex than with vitamins or minerals.
4. Greens and Functional Nutrition Gummies Are Emerging
Greens supplements — traditionally sold as powders with challenging taste profiles — are now entering the gummy format. Brands are finding that consumers who struggle with the taste and preparation of greens powders are receptive to a convenient gummy alternative, even at lower active doses.
The formulation challenge is significant. Greens concentrates, spirulina, chlorella, and vegetable extracts bring strong flavour profiles and colour instability. Achieving a palatable, visually consistent gummy that delivers meaningful nutrition requires a CDMO with specific expertise in botanical and functional ingredient integration.
This is an early-stage trend, but brands moving quickly have a meaningful first-mover advantage in retail positioning — particularly in natural and health food retail channels where greens products already have strong shelf presence.
5. Personalization and Targeted Formulas
The one-size-fits-all supplement era is ending. Consumers now expect products tailored to their age, gender, lifestyle, or specific health goals. Brands are succeeding with hyper-targeted products like "gummies for women over 40," "athlete recovery gummies," or "prenatal gummies." Custom formulation makes this possible — and manufacturers like Excelsia Labs can develop these targeted products efficiently.
What This Means for Procurement Teams
The trends above all point in the same direction: gummy supplement formulation is becoming more technically demanding, not less. The CDMO market is bifurcating between manufacturers capable of handling high-actives, complex botanicals, and custom formulation — and those that are not.
Procurement teams evaluating CDMOs in 2025 should be asking harder questions:
Can you demonstrate stability data for high-dose actives like creatine or collagen? What is your maximum active load per gummy? Do you have in-house R&D capability or do you rely on external formulation partners? What certifications do you hold and which markets do they cover?
The answers will quickly separate serious manufacturing partners from those operating at the commodity end of the market.
EU GMP and BRCGS certifications are the minimum quality standards for brands selling into European markets or major international retail. These aren't just credentials — they represent the quality management systems, batch records, deviation handling, and documentation rigour that protect your brand and your consumers.
Independent third-party testing programme
In-house QC is necessary but not sufficient. An ISO-accredited external lab with no commercial relationship to the manufacturer provides the independent verification that regulators, retailers, and savvy consumers are increasingly demanding.
Looking to Launch a Gummy Supplement in 2025?
Excelsia Labs is an EU GMP certified gummy CDMO based in Greece. We work with supplement brands, private label buyers, and retail chains across Europe and internationally — from initial formulation through to commercial production. If you're evaluating CDMOs for a 2025 launch, we'd welcome the conversation.
Contact
@2026 ExcelsiaLabs. All rights reserved.